Skip to main content
OpenTrials
Completed

NCT Number: NCT01603862

ThinkingFit: Combined Physical, Cognitive and Social Treatment in Mild Cognitive Impairment (MCI)

Dementia is serious problem and around 700 000 people are affected in the UK alone. Currently there is no cure however early diagnosis and effective treatment offers hope for reducing the impact. Dementia sufferers require care due to physical disability, cognitive deficits, social isolation and emotional symptoms (depression). Delaying the onset of dementia will improve quality of life for patients and reduce the cost of residential care (£42 000 per person per year).

People with mild cognitive impairment (MCI) are at high risk of developing dementia. They have impaired cognitive abilities, such as memory, but still manage their everyday activities. Studies show that 8 out of 10 people with MCI will have developed dementia 6 years after diagnosis.

Regular physical activities and performing a variety of cognitive activities reduce the risk of dementia and improves abilities and quality of life in healthy people. Therefore a combination of these activities may reduce the risk of developing dementia in MCI. The investigators want to see if they can develop a program which combines these activities in a fun and social way that gets people active and keeps them active. The aims are to improve fitness, cognition and quality of life. The investigators plan to use computers and the internet to help with the activities and to make them available to people who are isolated. Physical activity will involve walking from home, cognitive activities will be computer based games and puzzles and socialising will involve regular varied group-based activities. Participants (128) will be recruited from the UCL Derwent Memory Clinic and will complete a 26 week program. They will then be followed up yearly to monitor their progress. The main outcome of the study is engagement in the activities. The investigators will also measure fitness, cognition, quality of life and conversion to dementia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

North Essex Partnership Foundation NHS Trust

Harlow, Essex, cm20 1qx, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for patients with MCI

  • Patients fulfilling criteria for AMCI [Petersen et al. 2001b]:

i. Memory impairment for age and education ii. No impairment in other cognitive domains iii. Normal social activities iv. Patient is not demented

  • For the other subtypes of MCI, cognitive impairment in one or more nonmemory domain
  • Sedentary lifestyle with no regular participation in physical exercise defined as two or three times a week for at least 20 minutes duration, or participation in active sport more than once a week, in the previous six months.
  • Willing and able to give informed consent.
  • Availability and access to safe exercise environments, such as paths or roads with sidewalks for walking or cycling.
  • At low risk from serious adverse effects from increased physical activity as indicated by performance on the revised Physical activity readiness questionnaire (PARQ).

Exclusion criteria

Exclusion criteria

for patients with MCI

  • Type 1 (insulin dependent) diabetes mellitus.
  • Blood pressure of 160/100 mmHg or more.
  • Body weight more than 140% of ideal body weight.
  • Musculoskeletal or other medical problems preventing safe participation in regular moderate intensity exercise (65-77% of predicted maximum heart rate). This will include a resting tachycardia (heart rate above 100 bpm) and history of myocardial infarction or unstable angina within the last month.

Participants with modifiable exclusion criteria will be reconsidered after successful management. Patients will be referred for medical treatment prior to commencing exercise if indicated by the PARQ and the intervention will be guided by the PARmedX.

Participants taking medications affecting heart rate will need to be on a stable dosing regime for 3 months prior to commencing in order to control for potential spurious results on fitness measures caused by these treatments.

Treatment and study plan

ThinkingFit programme

Procedure

Combined physical, cognitive and social stimulation activties.

Primary outcomes

  1. Activity Compliance

    Time frame: Compliance with programmed activities will be assessed at the end of participation which is expected to be at 24 weeks

    Number of participants to have completed 50% or more of the programmed activity sessions during the intervention period.

Secondary outcomes

  1. Cardiovascular fitness measure

    Time frame: This will be measured at the start, after the control period (12 weeks) and after completion of the activity interventions at around 24 weeks.

    Cardiovascular fitness will be measured with a modified Siconolfi Step Test.

  2. Cognitive measures

    Time frame: This will be measured at the start, after the control period (12 weeks) and after completion of the activity interventions at around 24 weeks.

    Participants will complete the following cognitive measures:

    • Visual and auditory divided attention task
    • Verbal episodic encoding and recognition task
    • Halstead Trail Making test (TMT)
    • Verbal fluency
    • Working memory tests: digit span forwards/ backwards
  3. Measures of quality of life and everyday activities

    Time frame: This will be measured at the start, after the control period (12 weeks) and after completion of the activity interventions at around 24 weeks.

    Quality of life will be measured on the World Health Organization Quality of Life (WHOQOL) - BREF and change in every day activities on the Alzheimer's Disease Cooperative Study MCI Activities of Daily Living Scale (ADCS-MCI-ADL)

Sponsors and collaborators

Lead sponsor

Dr Thomas Dannhauser

Other Gov

Collaborators

  • University College, London

Registry information

Official study title

Piloting a Complex Intervention Involving Physical Exercise, Cognitive Training and Socialising to Delay the Onset of Dementia in Mild Cognitive Impairment

Acronym: ThinkingFit

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
May 23, 2012
Registry last updated
Apr 28, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.